Fran Visco
弗兰·维斯科
JD
Founder and President创始人兼主席
👥Biography 个人简介
Fran Visco, JD, is a breast cancer survivor and founder of the National Breast Cancer Coalition (NBCC), the largest breast cancer advocacy organization in the US. Since 1991, she has championed evidence-based advocacy, pushing Congress for increased research funding and patient involvement in clinical trial design and oversight.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
National Breast Cancer Coalition Leadership
Founded and led NBCC since 1991, mobilizing thousands of advocates and securing billions in federal research funding through landmark legislative campaigns including the Breast Cancer Research Program within the DOD.
Clinical Trials Access and Patient Involvement
Pioneered the model of training breast cancer advocates to participate meaningfully in scientific peer review and clinical trial design, fundamentally changing the relationship between patients and researchers.
Deadline 2020 Campaign
Launched the Deadline 2020 initiative to end breast cancer by 2020, focusing resources on metastatic disease prevention and catalyzing international scientific collaboration around stopping metastasis.
Representative Works 代表性著作
Project LEAD (Leadership, Education and Advocacy Development)
NBCC Program (1995)
Flagship science training program equipping patient advocates with skills to participate in research review, influencing hundreds of grant panels and clinical trial protocols nationally.
Breast Cancer Research Program (BCRP) Advocacy
US Department of Defense (1992)
NBCC advocacy secured the creation of the DOD BCRP, which has distributed over $3 billion for breast cancer research since its establishment.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 弗兰·维斯科 的研究动态
Follow Fran Visco's research updates
留下邮箱，当我们发布与 Fran Visco（National Breast Cancer Coalition）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment